JILLIAN PURVIS: Open Payments
NPI 1588327829 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 18 payments from 6 companies in 2025. Trend: 2023 $316 · 2024 $267 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 10 | $260 |
| Otsuka America Pharmaceutical, Inc. | 2 | $150 |
| UCB, Inc. | 3 | $68 |
| Novo Nordisk Inc | 1 | $23 |
| Celgene Corporation | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
Products named: VYVGART HYTRULO, REXULTI, VYVGART, Rystiggo, Wegovy, ZEPOSIA, BOTOX.
Industry payments across NC — which companies pay providers there.
